| Indicators | Browse All

Aditxt, Inc. (ADTX)

Healthcare | Biotechnology | Mountain View, United States | OTC Markets OTCPK
0.00 USD

Short-term:⯪☆☆☆☆Long-term:☆☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 4:14 a.m. EDT

The immediate outlook is severely compromised by the company's imminent delisting from Nasdaq due to repeated reverse split failures and rule breaches, creating extreme liquidity and execution risks that outweigh any speculative bounce potential. While recent headlines mention a massive overnight surge and a new 10% holder emerging following a SPAC deal, these events occur against a backdrop of catastrophic long-term performance where the stock has lost virtually 100% of its value over the last five years, with every single annual period showing double-digit declines. Fundamentally, the business is in distress with negative earnings, negative free cash flow, and a current ratio of just 0.064, indicating severe insolvency risks. There is no dividend support whatsoever, and the statistical forecasting models offer no reliable guidance given their very low confidence scores amidst such extreme volatility. Any attempt to enter now is a gamble on a company fighting to stay listed rather than an investment in a viable enterprise.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓1.741835
AutoARIMA1.768437
AutoETS1.907971
MSTL2.016297

Forecast horizon: 60 days | Selected: AutoTheta

Forecast Reliability
Score 22%
H-stat 682.10
Ljung-Box p 0.000
Jarque-Bera p 0.045
Excess Kurtosis -1.49
Attribute Value
Sector Healthcare
Revenue per Share 0.371
Market Cap 3,991,906
Forward P/E 0.00
Previous Name ADiTx Therapeutics, Inc.
Website https://www.aditxt.com

Info Dump

Attribute Value
52 Week Change -0.9999999
Address1 2,569 Wyandotte Street
Address2 Suite 101
All Time High 4,676,572,900,000.0
All Time Low 0.002
Ask 0.0041
Ask Size 364,810
Average Daily Volume10 Day 109,405,010
Average Daily Volume3 Month 416,744,387
Average Volume 416,744,387
Average Volume10Days 109,405,010
Bid 0.004
Bid Size 1,499,361
Book Value -861.428
City Mountain View
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.004
Current Ratio 0.064
Custom Price Alert Confidence LOW
Date Short Interest 1,781,481,600
Day High 0.0043
Day Low 0.0037
Display Name Aditxt
Earnings Timestamp End 1,755,892,800
Earnings Timestamp Start 1,755,547,200
Ebitda -18,075,768
Ebitda Margins 0.0
Enterprise To Ebitda -0.115
Enterprise To Revenue 144.437
Enterprise Value 2,070,645
Eps Forward -11.29
Eps Trailing Twelve Months -1,380.8
Esg Populated 0
Exchange PNK
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 1.0509
Fifty Day Average Change -1.0469
Fifty Day Average Change Percent -0.99619377
Fifty Two Week Change Percent -99.999985
Fifty Two Week High 31,974.48
Fifty Two Week High Change -31,974.477
Fifty Two Week High Change Percent -0.9999999
Fifty Two Week Low 0.002
Fifty Two Week Low Change 0.002
Fifty Two Week Low Change Percent 1.0
Fifty Two Week Range 0.002 - 31974.48
Financial Currency USD
First Trade Date Milliseconds 1,593,523,800,000
Float Shares 341,757
Forward Eps -11.29
Forward P E -0.00035429586
Free Cashflow -12,346,033
Full Exchange Name OTC Markets OTCPK
Full Time Employees 26
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.19894
Gross Profits 2,852
Has Pre Post Market Data 0
Held Percent Insiders 0.00064000004
Held Percent Institutions 0.0
Implied Shares Outstanding 997,976,542
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,779,062,400
Last Split Factor 1:27
Long Business Summary Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It develops ADI-100 for skin grafting, psoriasis, and type-1 diabetes. In addition, the company provides Pearsanta that develops molecular tests based on the mitochondrial DNA (mtDNA) to develop tests for early detection of cancer; Mitomic targets mutations in mitochondrial DNA (mtDNA) to detect disease; Mitomic prostate test a blood-based assay that quantifies the level of the 3.4kb mtDNA deletion; and Mitomic endometriosis test, a blood-based assay that quantifies the level of one or more mtDNA deletions. Further, it offers Adivir for commercial development of products to address significant unmet needs in infectious disease and population health; and Adifem address critical unmet needs in women health. The company has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.
Long Name Aditxt, Inc.
Market us_market
Market Cap 3,991,906
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_551021594
Most Recent Quarter 1,774,915,200
Name Change Date 2,026-07-13
Net Income To Common -53,338,868
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 4,091,703
Open 0.0042
Operating Cashflow -18,553,676
Operating Margins -358.73535
Payout Ratio 0.0
Phone 650 870 1200
Prev Name ADiTx Therapeutics, Inc.
Previous Close 0.004
Price Hint 4
Price To Book -0.000004643453
Price To Sales Trailing12 Months 278.45328
Profit Margins 0.0
Quick Ratio 0.021
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0
Regular Market Change Percent 0.0
Regular Market Day High 0.0043
Regular Market Day Low 0.0037
Regular Market Day Range 0.0037 - 0.0043
Regular Market Open 0.0042
Regular Market Previous Close 0.004
Regular Market Price 0.004
Regular Market Time 1,783,972,791
Regular Market Volume 17,046,250
Return On Assets -0.50756
Revenue Growth 10.944
Revenue Per Share 0.371
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 997,976,542
Shares Percent Shares Out 0.345
Shares Short 281,498
Shares Short Previous Month Date 1,778,803,200
Shares Short Prior Month 3,386
Short Name Aditxt, Inc.
Short Percent Of Float 0.345
Short Ratio 0.0
Source Interval 15
State CA
Symbol ADTX
Total Cash 268,852
Total Cash Per Share 0.33
Total Debt 4,233,669
Total Revenue 14,336
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1,380.8
Trailing Peg Ratio None
Triggerable 0
Two Hundred Day Average 2,025.3436
Two Hundred Day Average Change -2,025.3396
Two Hundred Day Average Change Percent -0.99999803
Type Disp Equity
Volume 17,046,250
Website https://www.aditxt.com
Zip 94,043